Randomized controlled trial of lobaplatin plus etoposide vs. cisplatin plus etoposide as first-line therapy in patients with extensive-stage small cell lung cancer

The majority of previous studies of lobaplatin in small cell lung cancer (SCLC) are small phase I–II studies. The present study aimed to verify the non-inferiority (in terms of efficacy) of lobaplatin plus etoposide (EL) vs. cisplatin plus etoposide (EP) in patients with previously untreated extensi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncol Lett
Hauptverfasser: Cheng, Ying, Fan, Yun, Liu, Xiaoqing, Liu, Yunpeng, Liu, Jiwei, Wang, Dong, Yu, Yan, Qin, Shukui, Liu, Wei, Huang, Cheng, Zhang, Helong, Liang, Jun, Shi, Jianhua, Sheng, Lijun, Yu, Hao
Format: Artigo
Sprache:Inglês
Veröffentlicht: D.A. Spandidos 2019
Schlagworte:
Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6447897/
https://ncbi.nlm.nih.gov/pubmed/30988825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.10125
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge